A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|New England Journal of Medicine|2024Cited by 151
Improved Left Ventricular Structure and Function After Successful Kidney TransplantationBernd Hewing, Fabian Halleck, Gert Baumann et al.|Kidney & Blood Pressure Research|2016Cited by 58
225.3: Randomized phase 2 trial of felzartamab in humoral transplant rejection.Katharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|Transplantation|2024Cited by 0